Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormonal Refractory Prostate Cancer”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT00738673
What this trial is testing

Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 37
Testing effectiveness (Phase 2)Study completedNCT00831467
What this trial is testing

Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease

Who this might be right for
Hormonal Refractory Prostate Cancer
CureVac 48
Post-approval studies (Phase 4)Active Not RecruitingNCT03016741
What this trial is testing

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+2 more
Northwestern University 100
Testing effectiveness (Phase 2)Study completedNCT00115635
What this trial is testing

Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Herlev Hospital 60
Large-scale testing (Phase 3)UnknownNCT03458559
What this trial is testing

Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy

Who this might be right for
Prostate Cancer Metastatic to Bone
Amsterdam UMC, location VUmc 402
Large-scale testing (Phase 3)Study completedNCT00002503
What this trial is testing

Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 204
Testing effectiveness (Phase 2)Ended earlyNCT00918385
What this trial is testing

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 57